The VSV-EBOPLUS collaborative research project on “Systems analysis of adult and pediatric responses to the VSV-ZEBOV Ebola vaccine” is aimed to decipher the immune and molecular signatures of adult and pediatric responses elicited by the rVSVrG-ZEBOV-GP vaccine, based on the replication-competent recombinant vesicular stomatitis virus (VSV) expressing a Zaire ebolavirus (EBOV) glycoprotein, the only Ebola vaccine with demonstrated 100% protective efficacy in humans.
VSV-EBOPLUS will apply advanced cutting-edge technologies and systems vaccinology approaches to characterize the signatures of the responses to rVSVrG-ZEBOV-GP vaccination in clinical studies conducted in three different continents (Europe, Africa, US), in almost 1’000 adults, adolescents and children.
An Affiliated Member will have unlimited access to VSV-EBOPLUS’s dissemination activities (plenary sessions at annual meetings and conferences, workshops, public online resources, and newsletters), training programs, impact sharing activities, and opportunities for commissioned research undertaken by VSV-EBOPLUS members for the benefit of project-external partners, in particular SMEs. Affiliate membership would effectively link you and the work of your organization with existing VSV-EBOPLUS members.
Here you can read how you can become an affiliated member